

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.57641824 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.57641824 |
| 3 | signal peptide processing (GO:0006465) | 4.85915516 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.73223694 |
| 5 | detection of other organism (GO:0098543) | 4.49162733 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 4.38765909 |
| 7 | detection of bacterium (GO:0016045) | 4.26792652 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 4.25235794 |
| 9 | protein retention in ER lumen (GO:0006621) | 4.19752681 |
| 10 | COPII vesicle coating (GO:0048208) | 4.11752963 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.03355155 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.03355155 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.91767040 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.91767040 |
| 15 | cellular extravasation (GO:0045123) | 3.91615375 |
| 16 | endocrine pancreas development (GO:0031018) | 3.89057543 |
| 17 | detection of external biotic stimulus (GO:0098581) | 3.87662385 |
| 18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.87457385 |
| 19 | regulation of mast cell degranulation (GO:0043304) | 3.84819102 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.82350968 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.79474441 |
| 22 | sequestering of metal ion (GO:0051238) | 3.69130773 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.63369740 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.63369740 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.63369740 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.63369740 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.63369740 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.63369740 |
| 29 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.60412172 |
| 30 | regulation of leukocyte degranulation (GO:0043300) | 3.58511717 |
| 31 | peptide hormone processing (GO:0016486) | 3.57716216 |
| 32 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.55925623 |
| 33 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.55161791 |
| 34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.54262856 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 3.53284302 |
| 36 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.52119061 |
| 37 | peptide catabolic process (GO:0043171) | 3.50382310 |
| 38 | * glycosphingolipid catabolic process (GO:0046479) | 3.49993787 |
| 39 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.49884017 |
| 40 | detection of biotic stimulus (GO:0009595) | 3.48379125 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.41811322 |
| 42 | positive regulation of nuclease activity (GO:0032075) | 3.36829585 |
| 43 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34758125 |
| 44 | granulocyte activation (GO:0036230) | 3.30292062 |
| 45 | positive regulation of mast cell degranulation (GO:0043306) | 3.25665509 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.25665509 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.25502151 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.25099133 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.23629433 |
| 50 | regulation of mast cell activation (GO:0033003) | 3.23283386 |
| 51 | B cell mediated immunity (GO:0019724) | 3.22944128 |
| 52 | response to muramyl dipeptide (GO:0032495) | 3.21388565 |
| 53 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.21270625 |
| 54 | negative regulation of bone resorption (GO:0045779) | 3.21072795 |
| 55 | microglial cell activation (GO:0001774) | 3.20638519 |
| 56 | protein maturation by protein folding (GO:0022417) | 3.18977068 |
| 57 | amino sugar catabolic process (GO:0046348) | 3.18491240 |
| 58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.18267109 |
| 59 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.18207445 |
| 60 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.15443340 |
| 61 | cellular response to unfolded protein (GO:0034620) | 3.14205212 |
| 62 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.12577453 |
| 63 | neutrophil activation (GO:0042119) | 3.10939097 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10562626 |
| 65 | regulation of gamma-delta T cell activation (GO:0046643) | 3.09065606 |
| 66 | positive regulation of leukocyte degranulation (GO:0043302) | 3.08618171 |
| 67 | * glycolipid catabolic process (GO:0019377) | 3.08213398 |
| 68 | keratan sulfate catabolic process (GO:0042340) | 3.07796640 |
| 69 | intracellular pH reduction (GO:0051452) | 3.07757671 |
| 70 | regulation of nuclease activity (GO:0032069) | 3.07025098 |
| 71 | pinocytosis (GO:0006907) | 3.05780792 |
| 72 | response to thyroid hormone (GO:0097066) | 3.03141644 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 3.01444324 |
| 74 | regulation of antigen processing and presentation (GO:0002577) | 3.00870658 |
| 75 | cellular response to topologically incorrect protein (GO:0035967) | 3.00138122 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 2.95282206 |
| 77 | ER-nucleus signaling pathway (GO:0006984) | 2.90138647 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90103655 |
| 79 | response to host (GO:0075136) | 2.90103655 |
| 80 | response to host defenses (GO:0052200) | 2.90103655 |
| 81 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89274325 |
| 82 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.87277781 |
| 83 | barbed-end actin filament capping (GO:0051016) | 2.86171041 |
| 84 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.85958648 |
| 85 | regulation of tolerance induction (GO:0002643) | 2.83594379 |
| 86 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.82393418 |
| 87 | myeloid dendritic cell differentiation (GO:0043011) | 2.81643145 |
| 88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81050354 |
| 89 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.80859808 |
| 90 | N-acetylneuraminate metabolic process (GO:0006054) | 2.80655264 |
| 91 | pH reduction (GO:0045851) | 2.80644803 |
| 92 | regulation of superoxide anion generation (GO:0032928) | 2.80490454 |
| 93 | cellular response to type I interferon (GO:0071357) | 2.80243627 |
| 94 | type I interferon signaling pathway (GO:0060337) | 2.80243627 |
| 95 | regulation of T cell tolerance induction (GO:0002664) | 2.79734296 |
| 96 | toxin transport (GO:1901998) | 2.78990920 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.78030408 |
| 98 | vesicle coating (GO:0006901) | 2.77816205 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 2.76343087 |
| 100 | response to peptidoglycan (GO:0032494) | 2.75301710 |
| 101 | regulation of regulated secretory pathway (GO:1903305) | 2.75155401 |
| 102 | response to type I interferon (GO:0034340) | 2.75025048 |
| 103 | positive regulation of type 2 immune response (GO:0002830) | 2.74991391 |
| 104 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.71974072 |
| 105 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.71810817 |
| 106 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71412250 |
| 107 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.70276500 |
| 108 | ER overload response (GO:0006983) | 2.69985161 |
| 109 | positive regulation of B cell differentiation (GO:0045579) | 2.69712778 |
| 110 | regulation of mononuclear cell migration (GO:0071675) | 2.69252541 |
| 111 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.69101547 |
| 112 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.68997982 |
| 113 | negative regulation of tissue remodeling (GO:0034104) | 2.68722278 |
| 114 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.68370230 |
| 115 | response to laminar fluid shear stress (GO:0034616) | 2.67496728 |
| 116 | exocrine pancreas development (GO:0031017) | 2.66412602 |
| 117 | positive regulation of interferon-alpha production (GO:0032727) | 2.66228081 |
| 118 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.65898172 |
| 119 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.65047116 |
| 120 | peptidyl-asparagine modification (GO:0018196) | 2.64884213 |
| 121 | regulation of podosome assembly (GO:0071801) | 2.64080448 |
| 122 | regulation of macrophage cytokine production (GO:0010935) | 2.63994304 |
| 123 | valine metabolic process (GO:0006573) | 2.63584468 |
| 124 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.61456064 |
| 125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59322081 |
| 126 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.58755027 |
| 127 | negative regulation of innate immune response (GO:0045824) | 2.58677127 |
| 128 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58673314 |
| 129 | regulation of monocyte chemotaxis (GO:0090025) | 2.58524885 |
| 130 | respiratory burst (GO:0045730) | 2.58104205 |
| 131 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.57670175 |
| 132 | defense response to protozoan (GO:0042832) | 2.57269911 |
| 133 | response to endoplasmic reticulum stress (GO:0034976) | 2.55519391 |
| 134 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.55398751 |
| 135 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.53235299 |
| 136 | glandular epithelial cell differentiation (GO:0002067) | 2.51507574 |
| 137 | macroautophagy (GO:0016236) | 2.50469553 |
| 138 | negative regulation of bone remodeling (GO:0046851) | 2.50031243 |
| 139 | amyloid precursor protein catabolic process (GO:0042987) | 2.49889473 |
| 140 | regulation of interferon-alpha production (GO:0032647) | 2.49546265 |
| 141 | macrophage activation (GO:0042116) | 2.48713464 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48692733 |
| 143 | endosome to melanosome transport (GO:0035646) | 2.47113310 |
| 144 | endosome to pigment granule transport (GO:0043485) | 2.47113310 |
| 145 | cellular response to vitamin D (GO:0071305) | 2.45396966 |
| 146 | protein N-linked glycosylation (GO:0006487) | 2.42382560 |
| 147 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.41380664 |
| 148 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.40114663 |
| 149 | 4-hydroxyproline metabolic process (GO:0019471) | 2.38676027 |
| 150 | mannose metabolic process (GO:0006013) | 2.35869254 |
| 151 | negative regulation of norepinephrine secretion (GO:0010700) | 2.35388997 |
| 152 | apoptotic cell clearance (GO:0043277) | 2.34619670 |
| 153 | eosinophil chemotaxis (GO:0048245) | 2.33952880 |
| 154 | type B pancreatic cell development (GO:0003323) | 2.32168691 |
| 155 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.32009284 |
| 156 | response to host immune response (GO:0052572) | 2.32009284 |
| 157 | oligosaccharide catabolic process (GO:0009313) | 2.31293360 |
| 158 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.30185561 |
| 159 | L-phenylalanine catabolic process (GO:0006559) | 2.30185561 |
| 160 | reactive oxygen species biosynthetic process (GO:1903409) | 2.28989346 |
| 161 | positive regulation of insulin secretion (GO:0032024) | 2.28959265 |
| 162 | tricarboxylic acid metabolic process (GO:0072350) | 2.25881019 |
| 163 | T-helper 1 type immune response (GO:0042088) | 2.25112866 |
| 164 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.24327823 |
| 165 | positive regulation of p38MAPK cascade (GO:1900745) | 2.23009273 |
| 166 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.22549026 |
| 167 | glandular epithelial cell development (GO:0002068) | 2.22034081 |
| 168 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.19269545 |
| 169 | response to unfolded protein (GO:0006986) | 2.18979346 |
| 170 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.18118016 |
| 171 | regulation of cholesterol homeostasis (GO:2000188) | 2.17687848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.84291508 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.67583594 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.52258543 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.19902867 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80307522 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75139259 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74984639 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.71113369 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70185766 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57407894 |
| 11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53343028 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46499486 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.42396756 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.38484594 |
| 15 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.28696438 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.15595719 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10356303 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09762113 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.09077756 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06963449 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04416838 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.02449718 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01189036 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99015696 |
| 25 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.92163863 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84963368 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75377004 |
| 28 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75355283 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72792518 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72055035 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71648259 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67857992 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.67287895 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66495569 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63111862 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.63088387 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62005073 |
| 38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60329405 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60270982 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59825057 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.59774419 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58725217 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55470765 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.55326979 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53721972 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53546278 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52016875 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47385689 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46768545 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46219538 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46021901 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45516462 |
| 53 | MYB_26560356_Chip-Seq_TH2_Human | 1.45006866 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.43326204 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42777019 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42650203 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42560667 |
| 58 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39462359 |
| 59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37198702 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37146069 |
| 61 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.36796592 |
| 62 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35799190 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35563008 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32020261 |
| 65 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31582675 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30573216 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28949533 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28659409 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28438167 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26718729 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26464643 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24303921 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23088427 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22798876 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.22523947 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22379272 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21904979 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21310451 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21195141 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.21156926 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20945730 |
| 82 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20871687 |
| 83 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18554480 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17208543 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14669616 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14357323 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 1.14279482 |
| 88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14040274 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13597961 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13090893 |
| 91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12864227 |
| 92 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10542440 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07864703 |
| 94 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07687765 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07328099 |
| 96 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06241422 |
| 97 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05843299 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05607174 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05533971 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04724608 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04231645 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03103765 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02146738 |
| 104 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02000386 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01925672 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00885139 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00197146 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99402326 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98290068 |
| 110 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98057940 |
| 111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96846343 |
| 112 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.96620235 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96578054 |
| 114 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94964945 |
| 115 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94912960 |
| 116 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94863709 |
| 117 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92973162 |
| 118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92169055 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92046449 |
| 120 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92038354 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91178382 |
| 122 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90946687 |
| 123 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89602309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.94392995 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.79026293 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.27218732 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.14892214 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.49597326 |
| 6 | MP0009840_abnormal_foam_cell | 2.46102173 |
| 7 | MP0003195_calcinosis | 2.36525010 |
| 8 | MP0002693_abnormal_pancreas_physiology | 2.34678176 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.29164759 |
| 10 | MP0006082_CNS_inflammation | 2.17025682 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.15369617 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.04344122 |
| 13 | MP0003436_decreased_susceptibility_to | 2.02944468 |
| 14 | MP0000013_abnormal_adipose_tissue | 1.95718300 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 1.94769351 |
| 16 | MP0003724_increased_susceptibility_to | 1.90385656 |
| 17 | MP0005365_abnormal_bile_salt | 1.90128546 |
| 18 | MP0005451_abnormal_body_composition | 1.89728990 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 1.86632416 |
| 20 | MP0005671_abnormal_response_to | 1.86580459 |
| 21 | MP0001944_abnormal_pancreas_morphology | 1.86156520 |
| 22 | MP0002419_abnormal_innate_immunity | 1.85266555 |
| 23 | MP0008260_abnormal_autophagy | 1.81718270 |
| 24 | MP0000685_abnormal_immune_system | 1.81687240 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.81677966 |
| 26 | MP0005220_abnormal_exocrine_pancreas | 1.80496587 |
| 27 | MP0000604_amyloidosis | 1.80025574 |
| 28 | MP0004043_abnormal_pH_regulation | 1.78388548 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.77115707 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.75063152 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.74566894 |
| 32 | MP0005310_abnormal_salivary_gland | 1.71950273 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.67986159 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.65318897 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.64975242 |
| 36 | MP0001790_abnormal_immune_system | 1.64703448 |
| 37 | MP0005387_immune_system_phenotype | 1.64703448 |
| 38 | MP0009785_altered_susceptibility_to | 1.62559148 |
| 39 | MP0003828_pulmonary_edema | 1.58855293 |
| 40 | MP0005025_abnormal_response_to | 1.58333080 |
| 41 | MP0000858_altered_metastatic_potential | 1.57717301 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.54932856 |
| 43 | MP0008004_abnormal_stomach_pH | 1.54029292 |
| 44 | MP0009278_abnormal_bone_marrow | 1.53862013 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.41992833 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.41167899 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.38283177 |
| 48 | MP0003252_abnormal_bile_duct | 1.37817769 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.37570605 |
| 50 | MP0003866_abnormal_defecation | 1.37495694 |
| 51 | MP0004510_myositis | 1.36881556 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.33003226 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.32875299 |
| 54 | MP0004883_abnormal_blood_vessel | 1.29908097 |
| 55 | MP0003283_abnormal_digestive_organ | 1.28970128 |
| 56 | MP0006054_spinal_hemorrhage | 1.28593149 |
| 57 | MP0003448_altered_tumor_morphology | 1.27625017 |
| 58 | MP0002723_abnormal_immune_serum | 1.27576733 |
| 59 | MP0008469_abnormal_protein_level | 1.27515043 |
| 60 | MP0002928_abnormal_bile_duct | 1.27425314 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 1.27154299 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.26055756 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.26055756 |
| 64 | MP0005166_decreased_susceptibility_to | 1.25353355 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.24053706 |
| 66 | MP0001849_ear_inflammation | 1.22065602 |
| 67 | MP0005085_abnormal_gallbladder_physiolo | 1.21071552 |
| 68 | MP0001819_abnormal_immune_cell | 1.21030350 |
| 69 | MP0002405_respiratory_system_inflammati | 1.20654113 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.20489436 |
| 71 | MP0002398_abnormal_bone_marrow | 1.18954833 |
| 72 | MP0001756_abnormal_urination | 1.17275245 |
| 73 | MP0003303_peritoneal_inflammation | 1.16717134 |
| 74 | MP0002420_abnormal_adaptive_immunity | 1.16433734 |
| 75 | MP0008875_abnormal_xenobiotic_pharmacok | 1.13396392 |
| 76 | MP0005164_abnormal_response_to | 1.13246296 |
| 77 | MP0003091_abnormal_cell_migration | 1.12280159 |
| 78 | MP0000609_abnormal_liver_physiology | 1.11929677 |
| 79 | MP0000689_abnormal_spleen_morphology | 1.11324658 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.11041531 |
| 81 | MP0001853_heart_inflammation | 1.10917480 |
| 82 | MP0005360_urolithiasis | 1.10525946 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.09755991 |
| 84 | MP0002429_abnormal_blood_cell | 1.09016459 |
| 85 | MP0004947_skin_inflammation | 1.08680882 |
| 86 | MP0002118_abnormal_lipid_homeostasis | 1.08187293 |
| 87 | MP0008438_abnormal_cutaneous_collagen | 1.06635923 |
| 88 | MP0002254_reproductive_system_inflammat | 1.06567493 |
| 89 | MP0001800_abnormal_humoral_immune | 1.06055335 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 1.04876075 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 1.04701528 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 1.04266968 |
| 93 | MP0002722_abnormal_immune_system | 1.03665987 |
| 94 | MP0001765_abnormal_ion_homeostasis | 1.03650348 |
| 95 | MP0003075_altered_response_to | 1.02608484 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.99486589 |
| 97 | MP0003186_abnormal_redox_activity | 0.98596069 |
| 98 | MP0003329_amyloid_beta_deposits | 0.97658022 |
| 99 | MP0005332_abnormal_amino_acid | 0.97422473 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.97022958 |
| 101 | MP0002132_abnormal_respiratory_system | 0.96527228 |
| 102 | MP0009763_increased_sensitivity_to | 0.96433277 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.96219067 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.95978691 |
| 105 | MP0003795_abnormal_bone_structure | 0.94686010 |
| 106 | MP0002933_joint_inflammation | 0.94613561 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.94111770 |
| 108 | MP0003279_aneurysm | 0.94098851 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 0.94082759 |
| 110 | MP0005390_skeleton_phenotype | 0.93984608 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.92859994 |
| 112 | MP0003868_abnormal_feces_composition | 0.92636259 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.91643367 |
| 114 | MP0009764_decreased_sensitivity_to | 0.91037788 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.90553918 |
| 116 | MP0003690_abnormal_glial_cell | 0.90003928 |
| 117 | MP0000490_abnormal_crypts_of | 0.89716231 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.89651804 |
| 119 | MP0001851_eye_inflammation | 0.89575878 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.88237695 |
| 121 | MP0003806_abnormal_nucleotide_metabolis | 0.87627615 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.86124477 |
| 123 | MP0001873_stomach_inflammation | 0.85416685 |
| 124 | MP0000343_altered_response_to | 0.83454722 |
| 125 | MP0005670_abnormal_white_adipose | 0.82585172 |
| 126 | MP0005083_abnormal_biliary_tract | 0.82096483 |
| 127 | MP0000249_abnormal_blood_vessel | 0.80662612 |
| 128 | MP0005023_abnormal_wound_healing | 0.80334387 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.79965685 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.79102480 |
| 131 | MP0000371_diluted_coat_color | 0.79054412 |
| 132 | MP0003763_abnormal_thymus_physiology | 0.79022616 |
| 133 | MP0001542_abnormal_bone_strength | 0.78239926 |
| 134 | MP0000598_abnormal_liver_morphology | 0.77327712 |
| 135 | MP0000716_abnormal_immune_system | 0.76777669 |
| 136 | MP0001958_emphysema | 0.76436819 |
| 137 | MP0005167_abnormal_blood-brain_barrier | 0.75756993 |
| 138 | MP0005076_abnormal_cell_differentiation | 0.74228791 |
| 139 | MP0005165_increased_susceptibility_to | 0.73692470 |
| 140 | MP0001663_abnormal_digestive_system | 0.72924813 |
| 141 | MP0000920_abnormal_myelination | 0.71010108 |
| 142 | MP0004808_abnormal_hematopoietic_stem | 0.66580672 |
| 143 | MP0010307_abnormal_tumor_latency | 0.60591257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.43021974 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.39181579 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 5.37163827 |
| 4 | Dysostosis multiplex (HP:0000943) | 4.98139258 |
| 5 | Mucopolysacchariduria (HP:0008155) | 4.47623532 |
| 6 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.47623532 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.44619411 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.44619411 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.44619411 |
| 10 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.11774682 |
| 11 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.11774682 |
| 12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.11774682 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.09457185 |
| 14 | Hypoglycemic seizures (HP:0002173) | 4.00270393 |
| 15 | Symptomatic seizures (HP:0011145) | 3.75559159 |
| 16 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.70817166 |
| 17 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.50781721 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.38814462 |
| 19 | Purpura (HP:0000979) | 3.32903936 |
| 20 | Amyloidosis (HP:0011034) | 3.32827199 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.25179391 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.24459471 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.09755929 |
| 24 | Obstructive lung disease (HP:0006536) | 3.09755929 |
| 25 | Ketoacidosis (HP:0001993) | 3.09333887 |
| 26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.08403564 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.07330644 |
| 28 | Late onset (HP:0003584) | 2.99574735 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.98737879 |
| 30 | Recurrent abscess formation (HP:0002722) | 2.97569766 |
| 31 | Stomatitis (HP:0010280) | 2.90521579 |
| 32 | Disinhibition (HP:0000734) | 2.86767614 |
| 33 | Optic neuritis (HP:0100653) | 2.85982726 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.85982726 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.85435451 |
| 36 | Hepatosplenomegaly (HP:0001433) | 2.84358829 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.81464462 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.81009863 |
| 39 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.77919560 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.76492065 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.76492065 |
| 42 | Upper motor neuron abnormality (HP:0002127) | 2.74136943 |
| 43 | Progressive neurologic deterioration (HP:0002344) | 2.65898773 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.62354712 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.61928505 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61893881 |
| 47 | Axonal loss (HP:0003447) | 2.61216141 |
| 48 | Retinal atrophy (HP:0001105) | 2.55699580 |
| 49 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.55540613 |
| 50 | Loss of speech (HP:0002371) | 2.55004759 |
| 51 | Meningitis (HP:0001287) | 2.53445480 |
| 52 | Beaking of vertebral bodies (HP:0004568) | 2.51690321 |
| 53 | Urticaria (HP:0001025) | 2.48485400 |
| 54 | Increased serum ferritin (HP:0003281) | 2.48420119 |
| 55 | Hyperglycemia (HP:0003074) | 2.48023652 |
| 56 | Nuclear cataract (HP:0100018) | 2.46529338 |
| 57 | Mutism (HP:0002300) | 2.41529841 |
| 58 | Recurrent viral infections (HP:0004429) | 2.39184681 |
| 59 | Joint hemorrhage (HP:0005261) | 2.38614979 |
| 60 | Epistaxis (HP:0000421) | 2.35447157 |
| 61 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34930356 |
| 62 | Protuberant abdomen (HP:0001538) | 2.33866991 |
| 63 | Large for gestational age (HP:0001520) | 2.30700898 |
| 64 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.29533150 |
| 65 | Ketosis (HP:0001946) | 2.29091279 |
| 66 | Abnormality of the nasal mucosa (HP:0000433) | 2.28853327 |
| 67 | Cellulitis (HP:0100658) | 2.28550872 |
| 68 | Progressive visual loss (HP:0000529) | 2.27639975 |
| 69 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27312405 |
| 70 | Gingival bleeding (HP:0000225) | 2.26239238 |
| 71 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.25746936 |
| 72 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.25746936 |
| 73 | Abdominal distention (HP:0003270) | 2.22823286 |
| 74 | Hemoptysis (HP:0002105) | 2.21680276 |
| 75 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19742228 |
| 76 | Prolonged bleeding time (HP:0003010) | 2.19318048 |
| 77 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.16945373 |
| 78 | Myositis (HP:0100614) | 2.16847213 |
| 79 | Cervical subluxation (HP:0003308) | 2.16800534 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.15300170 |
| 81 | Gout (HP:0001997) | 2.15213725 |
| 82 | Vasculitis (HP:0002633) | 2.14755896 |
| 83 | Colitis (HP:0002583) | 2.14466709 |
| 84 | Gastrointestinal infarctions (HP:0005244) | 2.13617698 |
| 85 | Glomerulonephritis (HP:0000099) | 2.12160383 |
| 86 | Hematochezia (HP:0002573) | 2.09975208 |
| 87 | Encephalitis (HP:0002383) | 2.07606077 |
| 88 | Thoracic kyphosis (HP:0002942) | 2.06479169 |
| 89 | Conjunctival telangiectasia (HP:0000524) | 2.05740895 |
| 90 | Xanthomatosis (HP:0000991) | 2.05641081 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.04401772 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.02973992 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 2.02282861 |
| 94 | Prolonged partial thromboplastin time (HP:0003645) | 2.00809118 |
| 95 | Decreased circulating renin level (HP:0003351) | 2.00547628 |
| 96 | Increased IgE level (HP:0003212) | 1.99711550 |
| 97 | Petechiae (HP:0000967) | 1.99630851 |
| 98 | Increased IgM level (HP:0003496) | 1.99405192 |
| 99 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98618887 |
| 100 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.98504300 |
| 101 | Abnormal glycosylation (HP:0012345) | 1.97289576 |
| 102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.97289576 |
| 103 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.97289576 |
| 104 | Abnormal protein glycosylation (HP:0012346) | 1.97289576 |
| 105 | Keratoconjunctivitis sicca (HP:0001097) | 1.96156240 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 1.96143195 |
| 107 | Nasal polyposis (HP:0100582) | 1.95943678 |
| 108 | Ovoid vertebral bodies (HP:0003300) | 1.94804773 |
| 109 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94367657 |
| 110 | Abnormality of complement system (HP:0005339) | 1.92988367 |
| 111 | Pustule (HP:0200039) | 1.92696273 |
| 112 | Inflammation of the large intestine (HP:0002037) | 1.92284070 |
| 113 | Tetraparesis (HP:0002273) | 1.91757415 |
| 114 | Bone pain (HP:0002653) | 1.91603972 |
| 115 | Poor head control (HP:0002421) | 1.90710941 |
| 116 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.90517861 |
| 117 | Osteomyelitis (HP:0002754) | 1.90093594 |
| 118 | Gastrointestinal inflammation (HP:0004386) | 1.89182300 |
| 119 | Conjugated hyperbilirubinemia (HP:0002908) | 1.88532275 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 1.87429056 |
| 121 | Abnormal pancreas size (HP:0012094) | 1.86949475 |
| 122 | Abnormal platelet volume (HP:0011876) | 1.85938248 |
| 123 | Cerebral palsy (HP:0100021) | 1.85350678 |
| 124 | Neurofibrillary tangles (HP:0002185) | 1.85214381 |
| 125 | Disproportionate short-trunk short stature (HP:0003521) | 1.84322677 |
| 126 | Malnutrition (HP:0004395) | 1.84185936 |
| 127 | Joint stiffness (HP:0001387) | 1.84072877 |
| 128 | Polyneuropathy (HP:0001271) | 1.84072116 |
| 129 | Arterial thrombosis (HP:0004420) | 1.83925568 |
| 130 | Polycythemia (HP:0001901) | 1.83885377 |
| 131 | Orchitis (HP:0100796) | 1.83527387 |
| 132 | Thrombocytosis (HP:0001894) | 1.82131582 |
| 133 | Hypokalemia (HP:0002900) | 1.82042854 |
| 134 | Asymmetric septal hypertrophy (HP:0001670) | 1.81866945 |
| 135 | Spondylolisthesis (HP:0003302) | 1.81550278 |
| 136 | Premature loss of primary teeth (HP:0006323) | 1.81302061 |
| 137 | IgM deficiency (HP:0002850) | 1.80970065 |
| 138 | Abnormal platelet function (HP:0011869) | 1.79461465 |
| 139 | Impaired platelet aggregation (HP:0003540) | 1.79461465 |
| 140 | Diminished motivation (HP:0000745) | 1.79020732 |
| 141 | Insulin resistance (HP:0000855) | 1.78418060 |
| 142 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.77998154 |
| 143 | Recurrent skin infections (HP:0001581) | 1.75103889 |
| 144 | Thoracolumbar scoliosis (HP:0002944) | 1.74559210 |
| 145 | Pathologic fracture (HP:0002756) | 1.72577653 |
| 146 | Myocardial infarction (HP:0001658) | 1.72459180 |
| 147 | Periodontitis (HP:0000704) | 1.72177268 |
| 148 | Pulmonary infiltrates (HP:0002113) | 1.71432288 |
| 149 | Gingivitis (HP:0000230) | 1.71242993 |
| 150 | Nephritis (HP:0000123) | 1.70427507 |
| 151 | Type I transferrin isoform profile (HP:0003642) | 1.69514500 |
| 152 | Basal ganglia calcification (HP:0002135) | 1.67756859 |
| 153 | * Cardiomegaly (HP:0001640) | 1.66158946 |
| 154 | Complement deficiency (HP:0004431) | 1.66138079 |
| 155 | Abnormality of renin-angiotensin system (HP:0000847) | 1.64172558 |
| 156 | Hypoplasia of the odontoid process (HP:0003311) | 1.63013352 |
| 157 | Vertebral compression fractures (HP:0002953) | 1.61868808 |
| 158 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.60835811 |
| 159 | Hyperparathyroidism (HP:0000843) | 1.60799791 |
| 160 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.60274669 |
| 161 | Chronic otitis media (HP:0000389) | 1.59654580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.08670366 |
| 2 | INSRR | 3.85397968 |
| 3 | TAOK3 | 3.51103695 |
| 4 | MAPK15 | 3.40789924 |
| 5 | PRPF4B | 2.89543424 |
| 6 | IRAK3 | 2.81752557 |
| 7 | TRIB3 | 2.66320563 |
| 8 | PASK | 2.61322256 |
| 9 | FLT3 | 2.51573392 |
| 10 | TBK1 | 2.26510827 |
| 11 | MAP4K1 | 2.13472701 |
| 12 | TYK2 | 2.09699351 |
| 13 | FES | 2.00985819 |
| 14 | IRAK4 | 2.00443121 |
| 15 | PTK6 | 1.96280341 |
| 16 | FGR | 1.91094764 |
| 17 | KIT | 1.78846094 |
| 18 | SIK1 | 1.76689651 |
| 19 | ZAP70 | 1.70092198 |
| 20 | MAP3K14 | 1.68475797 |
| 21 | HIPK2 | 1.66843043 |
| 22 | TAOK2 | 1.61699216 |
| 23 | JAK3 | 1.61062346 |
| 24 | EPHA3 | 1.57975878 |
| 25 | TGFBR2 | 1.55458870 |
| 26 | JAK1 | 1.53622874 |
| 27 | BCKDK | 1.53277218 |
| 28 | TESK2 | 1.50599070 |
| 29 | MAP3K11 | 1.50484466 |
| 30 | FGFR4 | 1.49916134 |
| 31 | SCYL2 | 1.48270896 |
| 32 | GRK7 | 1.46778971 |
| 33 | EPHB1 | 1.42724883 |
| 34 | FRK | 1.38874147 |
| 35 | TAOK1 | 1.36570531 |
| 36 | NEK9 | 1.35978160 |
| 37 | MAP3K2 | 1.34965202 |
| 38 | MST1R | 1.33253356 |
| 39 | IKBKB | 1.25356531 |
| 40 | BTK | 1.23274401 |
| 41 | MAP3K13 | 1.21405067 |
| 42 | IKBKE | 1.18917415 |
| 43 | IRAK1 | 1.18839888 |
| 44 | TEC | 1.18651213 |
| 45 | CSK | 1.18379086 |
| 46 | MAP2K3 | 1.16948318 |
| 47 | JAK2 | 1.12856014 |
| 48 | ITK | 1.11522814 |
| 49 | TNK2 | 1.10764169 |
| 50 | SMG1 | 1.09617296 |
| 51 | TXK | 1.06355981 |
| 52 | BLK | 1.04227136 |
| 53 | MOS | 1.02867317 |
| 54 | CDC42BPA | 1.02340288 |
| 55 | MAP2K2 | 1.00310412 |
| 56 | CSF1R | 0.99910249 |
| 57 | GRK6 | 0.98116614 |
| 58 | MAP3K3 | 0.96527836 |
| 59 | SYK | 0.94938465 |
| 60 | DDR2 | 0.94189101 |
| 61 | MET | 0.92557009 |
| 62 | MST4 | 0.92220558 |
| 63 | KSR2 | 0.91281288 |
| 64 | MAP3K1 | 0.91225640 |
| 65 | PRKD2 | 0.89928089 |
| 66 | PIM2 | 0.89184702 |
| 67 | PIK3CG | 0.87767528 |
| 68 | CHUK | 0.85532864 |
| 69 | YES1 | 0.82661202 |
| 70 | FGFR3 | 0.82660250 |
| 71 | WNK4 | 0.81820641 |
| 72 | MATK | 0.79760154 |
| 73 | LRRK2 | 0.79075376 |
| 74 | NLK | 0.76934232 |
| 75 | PKN2 | 0.76824341 |
| 76 | TTN | 0.76460562 |
| 77 | ICK | 0.75621764 |
| 78 | DYRK1B | 0.75342822 |
| 79 | MARK3 | 0.74882823 |
| 80 | LYN | 0.73719197 |
| 81 | WNK3 | 0.73692988 |
| 82 | PDGFRA | 0.73092359 |
| 83 | MAP3K8 | 0.72951092 |
| 84 | MAP3K6 | 0.71943987 |
| 85 | ABL2 | 0.70017811 |
| 86 | CAMKK2 | 0.68783472 |
| 87 | RIPK1 | 0.68414359 |
| 88 | MAPK7 | 0.67820476 |
| 89 | TGFBR1 | 0.67731009 |
| 90 | PTK2 | 0.67592347 |
| 91 | EPHA2 | 0.67186324 |
| 92 | STK10 | 0.65883638 |
| 93 | BMPR2 | 0.61905840 |
| 94 | CAMK1D | 0.61467222 |
| 95 | LCK | 0.61263836 |
| 96 | RIPK4 | 0.58546108 |
| 97 | TIE1 | 0.57204794 |
| 98 | MAP3K5 | 0.54951238 |
| 99 | MARK2 | 0.54850065 |
| 100 | BMPR1B | 0.53423780 |
| 101 | CDK4 | 0.53297274 |
| 102 | PDPK1 | 0.52755248 |
| 103 | RPS6KA4 | 0.52542560 |
| 104 | PRKG2 | 0.52229662 |
| 105 | EPHB2 | 0.51750892 |
| 106 | HCK | 0.51018760 |
| 107 | PIM1 | 0.48481727 |
| 108 | RPS6KA2 | 0.47989611 |
| 109 | MAP2K6 | 0.47777810 |
| 110 | EIF2AK3 | 0.47301497 |
| 111 | PDK1 | 0.45918842 |
| 112 | IGF1R | 0.45591919 |
| 113 | BMX | 0.45165830 |
| 114 | MAPKAPK2 | 0.44564777 |
| 115 | PRKCD | 0.44320278 |
| 116 | FYN | 0.44169822 |
| 117 | NME2 | 0.42221344 |
| 118 | SIK3 | 0.40128260 |
| 119 | MAPK12 | 0.39038106 |
| 120 | GSK3A | 0.38683420 |
| 121 | PDK2 | 0.38666291 |
| 122 | RET | 0.37309434 |
| 123 | PRKCH | 0.37142765 |
| 124 | TRPM7 | 0.35910047 |
| 125 | IRAK2 | 0.35682867 |
| 126 | DMPK | 0.35326994 |
| 127 | TESK1 | 0.35297794 |
| 128 | RPS6KA6 | 0.34956841 |
| 129 | ACVR1B | 0.34392517 |
| 130 | PAK1 | 0.33603008 |
| 131 | PAK4 | 0.32906747 |
| 132 | STK24 | 0.31020261 |
| 133 | ARAF | 0.30490627 |
| 134 | NTRK1 | 0.30377397 |
| 135 | CDK6 | 0.30307506 |
| 136 | KDR | 0.29434325 |
| 137 | RPS6KL1 | 0.29324447 |
| 138 | RPS6KC1 | 0.29324447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.01589318 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.87678079 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.36798348 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.16504641 |
| 5 | * Lysosome_Homo sapiens_hsa04142 | 3.06218961 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.91235149 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.52739365 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.22117612 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.20542311 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20482876 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.74322675 |
| 12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.71109292 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61987809 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59212256 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57070672 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53654413 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51423832 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48393630 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.48342655 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42450625 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40621075 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39683449 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37415562 |
| 24 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.36796106 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33165915 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.29755336 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21721075 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19470773 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19168692 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.19040543 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.17173157 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17066113 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16680319 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15574216 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15269483 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15084091 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14412309 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13506524 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.09409813 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05767858 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.04789814 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98221004 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 0.98220272 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97741508 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.97712979 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95072002 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94538782 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.93725908 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 0.93461783 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92708297 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.87838841 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87165312 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86867416 |
| 54 | * Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85956697 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.84829006 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 0.82936756 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82263622 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81582338 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81371591 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79996449 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.79529276 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78255130 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76968223 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76845928 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76052372 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75785443 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73839067 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73713339 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73316102 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72331604 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72172061 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71809982 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68138019 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67596461 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.66725455 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66724907 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65472745 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65304799 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.64923867 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64783554 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64429667 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63754803 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63256000 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62803376 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62319676 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62187126 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62140425 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.61716785 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60172759 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60079306 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59157443 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.58546796 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57892691 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.57629126 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57005788 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.56906720 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56626272 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55475197 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53440648 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53344950 |
| 101 | Apoptosis_Homo sapiens_hsa04210 | 0.53314726 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53154199 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53012802 |
| 104 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51455502 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51400719 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.49486014 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49278109 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48450053 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48144375 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46810465 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46122998 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45702640 |
| 113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45490651 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45440019 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44118364 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43606573 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43416186 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43140691 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41712030 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40735968 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40487689 |
| 122 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39230389 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38583800 |
| 124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38226396 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.36191537 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35957491 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35819411 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.35778427 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35551348 |
| 130 | Lysine degradation_Homo sapiens_hsa00310 | 0.34597279 |
| 131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33558020 |
| 132 | Allograft rejection_Homo sapiens_hsa05330 | 0.31984103 |
| 133 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31850139 |
| 134 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31794511 |
| 135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30870986 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24364328 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22506482 |
| 138 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20031095 |

